Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.42 USD | -1.66% | -5.73% | -26.18% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.18% | 8.08B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.90% | 22.02B | |
-17.84% | 20.9B | |
-9.47% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- BTIG Research Adjusts Legend Biotech Price Target to $75 From $65, Maintains Buy Rating